| Literature DB >> 31500521 |
Oriol Puig1, Otto M Henriksen1, Mark B Vestergaard1, Adam E Hansen1, Flemming L Andersen1, Claes N Ladefoged1, Egill Rostrup1, Henrik Bw Larsson1, Ulrich Lindberg1, Ian Law1.
Abstract
Arterial spin labelling (ASL) is a non-invasive magnetic resonance imaging (MRI) technique that may provide fully quantitative regional cerebral blood flow (rCBF) images. However, before its application in clinical routine, ASL needs to be validated against the clinical gold standard, 15O-H2O positron emission tomography (PET). We aimed to compare the two techniques by performing simultaneous quantitative ASL-MRI and 15O-H2O-PET examinations in a hybrid PET/MRI scanner. Duplicate rCBF measurements were performed in healthy young subjects (n = 14) in rest, during hyperventilation, and after acetazolamide (post-ACZ), yielding 63 combined PET/MRI datasets in total. Average global CBF by ASL-MRI and 15O-H2O-PET was not significantly different in any state (40.0 ± 6.5 and 40.6 ± 4.1 mL/100 g/min, respectively in rest, 24.5 ± 5.1 and 23.4 ± 4.8 mL/100 g/min, respectively, during hyperventilation, and 59.1 ± 10.4 and 64.7 ± 10.0 mL/100 g/min, respectively, post-ACZ). Overall, strong correlation between the two methods was found across all states (slope = 1.01, R2 = 0.82), while the correlations within individual states and of reactivity measures were weaker, in particular in rest (R2 = 0.05, p = 0.03). Regional distribution was similar, although ASL yielded higher perfusion and absolute reactivity in highly vascularized areas. In conclusion, ASL-MRI and 15O-H2O-PET measurements of rCBF are highly correlated across different perfusion states, but with variable correlation within and between hemodynamic states, and systematic differences in regional distribution.Entities:
Keywords: 15O-H2O-PET; Arterial spin labeling; PET/MRI; cerebral blood flow; perfusion
Year: 2019 PMID: 31500521 PMCID: PMC7370368 DOI: 10.1177/0271678X19874643
Source DB: PubMed Journal: J Cereb Blood Flow Metab ISSN: 0271-678X Impact factor: 6.200
Figure 4.Method specific regional cerebrovascular reactivity. Absolute (a) and relative (b) average reactivity maps between hyperventilation and resting state (blue, for CBF decrease) and post-ACZ and resting state (in red and yellow, for CBF increase) measured by 15O-H2O PET and ASL MRI.
Averaged global, gray matter and white matter cerebral blood flow (ml/100 g/min) assessed by 15O-H2O PET and ASL MRI.
| Hyperventilation ( | Rest ( | After-acetazolamide ( | ||||
|---|---|---|---|---|---|---|
| PET | ASL | PET | ASL | PET | ASL | |
| gCBF (mL/100 g/min) | 24.5 ± 5.1 | 23.4 ± 4.8 | 40.0 ± 6.5 | 40.6 ± 4.1 | 59.0 ± 10.4 | 61.7 ± 10.0 |
| Δabs gCBF (mL/100 g/min) | −14.5 ± 3.1 | −17.0 ± 5.1 | – | – | 19.7 ± 9.1 | 20.1 ± 7.7 |
| Δrel gCBF (%) | −37.3 ± 7.3 | −41.9 ± 11.7 | – | – | 51.4 ± 24.4 | 48.0 ± 17.2 |
| Intra-subject variability (%)[ | 7.8 | 14.9 | 7.1 | 5.1 | 7.3 | 6.0 |
| Inter-subject variability (%)[ | 20.6 | 14.9 | 14.7 | 8.6 | 16.2 | 15.2 |
| GM CBF (mL/100 g/min) | 27.5 ± 5.8 | 26.0 ± 5.6 | 44.8 ± 7.6 | 44.6 ± 4.5 | 66.7 ± 12.0 | 67.8 ± 10.4 |
| Δabs GM CBF (mL/100 g/min) | −16.3 ± 3.7 | −18.7 ± 5.7 | – | – | 22.5 ± 10.3 | 21.9 ± 8.1 |
| Δrel GM CBF (%) | −37.4 ± 7.3 | −41.7 ± 12.4 | – | – | 52.4 ± 24.5 | 47.5 ± 16.7 |
| WM CBF (mL/100 g/min) | 9.7 ± 1.9 | 9.5 ± 3.7 | 15.9 ± 2.7 | 15.4 ± 4.4 | 21.9 ± 3.7 | 21.8 ± 6.1 |
| Δabs WM CBF (mL/100 g/min) | −5.5 ± 1.6 | −5.7 ± 3.7 | – | – | 6.5 ± 3.6 | 5.9 ± 4.4 |
| Δrel WM CBF (%) | −36.0 ± 8.5 | −36.7 ± 19.2 | – | – | 43.9 ± 24.8 | 39.2 ± 34.1 |
Note: All values are the average ± standard deviation. n indicates number of observations. The change is calculated as the difference between the average CBF in resting state and individual measurements in hyperventilation or after acetazolamide. Only subjects with measurements in at least two states contribute the calculation of CBF changes. No significant differences between the two techniques in any of the states or regions, or in the assessment of relative or absolute changes between states were found. ASL: arterial spin labeling; PET: 15O-H2O positron emission tomography; CBF: cerebral blood flow; WM: White matter; GM: Gray matter; Δabs: absolute changes; Δrel: relative changes. aInter and intrasubject variability is calculated as the respective standard deviations from a variance component model divided by the population mean.
Correlation between CBF measurements and cerebral reactivity measured by ASL and PET.
| Whole brain | Gray matter | White matter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| slope [95% CI] | R[ | slope [95% CI] | R[ | slope [95% CI] | R[ | ||||
| Absolute CBF | |||||||||
| All states | 1.01 [0.92–1.10] | 0.82 | <0.001 | 0.96 [0.87–1.05] | 0.81 | <0.001 | 0.88 [0.70–1.06] | 0.51 | <0.001 |
| Rest | 0.26 [0.03–0.49] | 0.05 | 0.030 | 0.22 [0.04–0.39] | 0.10 | 0.021 | 0.54 [0.14–0.95] | 0.05 | 0.056 |
| HV | 0.73 [0.32–1.15] | 0.47 | 0.003 | 0.66 [0.25–1.07] | 0.39 | 0.005 | 0.04 [−0.80–0.89] | 0.01 | 0.912 |
| Post-ACZ | 0.55 [0.44–0.66] | 0.37 | <0.001 | 0.53 [0.44–0.62] | 0.34 | <0.001 | 0.30 [−0.56–1.17] | 0.13 | 0.448 |
| Absolute reactivity | |||||||||
| HV – rest | 0.43 [−0.41–1.28] | 0.12 | 0.271 | 0.07 [−0.47–0.61] | 0.00 | 0.778 | 0.32 [−0.70–0.76] | 0.02 | 0.929 |
| Post-ACZ – rest | 0.49 [0.32–0.66] | 0.26 | <0.001 | 0.49 [0.33–0.65] | 0.23 | <0.001 | −0.05 [−0.67–0.56] | 0.01 | 0.848 |
| Relative reactivity | |||||||||
| HV – rest | 0.80 [0.03–1.58] | 0.04 | 0.043 | 0.62 [−0.10–1.33] | 0.11 | 0.083 | −0.10 [−1.03–0.83] | 0.00 | 0.809 |
| Post-ACZ – rest | 0.40 [0.18–0.63] | 0.2 | 0.003 | 0.10 [0.18–0.63] | 0.19 | 0.003 | −0.34 [−1.04–0.35] | 0.00 | 0.291 |
Note: Slope and R2 are derived from the two-level variance component model (see Statistics). Changes are calculated as absolute and relative change from the average of the two resting measurements to each subsequent measurement.
HV: hyperventilation; Post-ACZ: post acetazolamide.
Figure 1.Correlation of gCBF measurements by 15O-H2O PET and ASL MRI.
Scatter plot of global cerebral blood flow (gCBF) measured by 15O-H2O PET and ASL MRI (a) and Bland–Altman plot showing the difference between the two methods against mean of the methods (b). In red, measurements during hyperventilation, in blue measurements in rest and in green measurements after acetazolamide. Orange line shows the modelled linear fit across all states and black lines the linear fit in each state from the model. In the scatter plots, grey line indicates the line of identity and in the Bland–Altman plots, solid black line indicates the average of the differences (bias) and the dashed lines the upper and lower limits of agreement (bias ± 2 SD).
Regional absolute CBF assessed by 15O-H2O PET and ASL MRI.
| Hyperventilation | Rest | Post-acetazolamide | ||||
|---|---|---|---|---|---|---|
| PET | ASL | PET | ASL | PET | ASL | |
| Frontal lobe | 29.0 ± 6.1 | 26.3 ± 5.5a | 47.3 ± 8.3 | 44.2 ± 4.6 | 69.4 ± 17.7 | 66.6 ± 8.7 |
| Parietal lobe | 27.1 ± 5.7 | 26.7 ± 7.9 | 43.2 ± 7.7 | 46.5 ± 5.4 | 65.0 ± 11.8 | 71.0 ± 11.4 |
| Temporal lobe | 24.9 ± 5.3 | 23.2 ± 4.6 | 41.3 ± 6.9 | 40.6 ± 4.8 | 61.8 ± 10.9 | 60.3 ± 10.4 |
| Occipital lobe | 28.4 ± 6.7 | 23.9 ± 7.0a | 43.1 ± 7.8 | 42.9 ± 7.4 | 67.1 ± 13.7 | 71.0 ± 17.1 |
| Cingulate | 28.5 ± 6.5 | 35.8 ± 7.8a | 49.6 ± 8.9 | 57.6 ± 7.4a | 72.5 ± 13.4 | 89.8 ± 12.6a |
| Cerebellum | 25.5 ± 5.1 | 19.5 ± 5.2a | 43.4 ± 6.3 | 39.3 ± 6.2a | 66.1 ± 13.6 | 65.7 ± 16.4 |
| Insula | 28.6 ± 5.9 | 32.4 ± 5.1a | 47.9 ± 8.4 | 54.2 ± 5.5a | 69.0 ± 12.8 | 77.5 ± 10.2a |
| Subcortical GM | 29.0 ± 5.6 | 27.7 ± 5.1 | 47.1 ± 7.6 | 44.8 ± 5.4 | 69.1 ± 13.9 | 69.2 ± 10.6 |
Note: CBF in mL/100 g/min. Values are displayed as average CBF ± SD. aSignificant differences (p < 0.05) between the two techniques. Subcortical GM = thalamus and basal ganglia
Figure 3.Global CBF reactivity. Scatter plots of (a) absolute (Δabs gCBF) and (b) relative (Δrel gCBF) between-state changes in global cerebral blood flow measured by 15O-H2O PET and ASL MRI, and of (c) relative gCBF change per % change of PaCO2 between hyperventilation and resting state. In blue, gCBF changes between hyperventilation and resting state and in green, changes between resting state and after the administration of acetazolamide. Orange line shows the linear fit from the model and the grey line indicates the line of identity.
Figure 2.Average ASL and PET CBF images in different perfusion states and differences between techniques.
Average 15O-H2O PET and ASL MRI perfusion measurements in the different perfusion states. The six columns on the left show average MRI ASL and 15O-H2O PET images during hyperventilation, in resting state and after acetazolamide. The four right columns show significant differences between the two techniques in each state and in all states combined. The t-value color scale is thresholded at a corrected P-value < 0.05 to show only the significantly different regions. In red-yellow ASL MRI > 15O-H2O PET and in blue ASL < 15O-H2O PET.